AGEN
Agenus Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Garo H. Armen
IPO Date
2000-02-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Agenus Inc.
CEO
Garo H. Armen
IPO Date
2000-02-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 4,233 |
| $3.84 |
| 28 Apr 2026 | Hirsch Susan B | director | A-Award | Acquired | 105,000 | $3.90 |
| 28 Apr 2026 | Buell Jennifer | director, officer: See Remarks | A-Award | Acquired | 300,000 | $3.90 |
| 28 Apr 2026 | Buell Jennifer | director, officer: See Remarks | A-Award | Acquired | 5,000 | $3.90 |
| 28 Apr 2026 | O'Day Steven J | Chief Medical Officer | A-Award | Acquired | 70,000 | $3.90 |
| 28 Apr 2026 | O'Day Steven J | Chief Medical Officer | A-Award | Acquired | 95,333 | $3.90 |
| 28 Apr 2026 | HARRISON THOMAS L | director | A-Award | Acquired | 122,500 | $3.90 |
| 28 Apr 2026 | Wright Timothy | director | A-Award | Acquired | 105,000 | $3.90 |
| 28 Apr 2026 | Charette Austin | Principal Accounting Officer | A-Award | Acquired | 5,000 | $3.90 |